Beijing Health (Holdings) Unveils Board Line-up and Committee Structure

Beijing Health (Holdings) Limited ( (HK:2389) ) has provided an announcement.

Beijing Health (Holdings) Limited has announced the composition of its board of directors, which consists of four executive directors, led by chairman Zhu Shi Xing and chief executive officer Liu Xue Heng, and four independent non-executive directors, underscoring a balanced governance framework in line with Hong Kong listing requirements. The company has also detailed the membership of its four key board committees—Audit, Remuneration, Nomination, and Investment and Risk Management—clarifying oversight responsibilities and reinforcing its internal control, risk management, and corporate governance structures for investors and other stakeholders.

The most recent analyst rating on (HK:2389) stock is a Hold with a HK$0.06 price target. To see the full list of analyst forecasts on Beijing Health (Holdings) Limited stock, see the HK:2389 Stock Forecast page.

More about Beijing Health (Holdings) Limited

Beijing Health (Holdings) Limited is a Hong Kong-listed company incorporated in the Cayman Islands, operating under stock code 2389. It is governed by a board comprising executive and independent non-executive directors, reflecting a typical corporate structure for listed entities focused on maintaining compliance and robust governance in the Hong Kong capital market.

Average Trading Volume: 1,920,934

Technical Sentiment Signal: Sell

Current Market Cap: HK$381.7M

See more data about 2389 stock on TipRanks’ Stock Analysis page.